These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8742942)

  • 1. Artificial neural networks as a novel approach to integrated pharmacokinetic-pharmacodynamic analysis.
    Gobburu JV; Chen EP
    J Pharm Sci; 1996 May; 85(5):505-10. PubMed ID: 8742942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Heuristic to Mathematical Modeling of Drugs Dissolution Profiles: Application of Artificial Neural Networks and Genetic Programming.
    Mendyk A; Güres S; Jachowicz R; Szlęk J; Polak S; Wiśniowska B; Kleinebudde P
    Comput Math Methods Med; 2015; 2015():863874. PubMed ID: 26101544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
    Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic model for educational simulations.
    van Meurs WL; Nikkelen E; Good ML
    IEEE Trans Biomed Eng; 1998 May; 45(5):582-90. PubMed ID: 9581056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.
    Lees P; Giraudel J; Landoni MF; Toutain PL
    J Vet Pharmacol Ther; 2004 Dec; 27(6):491-502. PubMed ID: 15601443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect pharmacodynamic response models do not require any parametric pharmacokinetic model to be fitted to effect-time data.
    Piotrovsky VK
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):723-9. PubMed ID: 9542723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of artificial neural networks to clinical pharmacology.
    Brier ME; Aronoff GR
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):510-4. PubMed ID: 8937935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Have artificial neural networks met expectations in drug discovery as implemented in QSAR framework?
    Dobchev D; Karelson M
    Expert Opin Drug Discov; 2016 Jul; 11(7):627-39. PubMed ID: 27149299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting intradialytic hypotension from experience, statistical models and artificial neural networks.
    Gabutti L; Machacek M; Marone C; Ferrari P
    J Nephrol; 2005; 18(4):409-16. PubMed ID: 16245245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the pharmacokinetics and pharmacodynamics of a unique oral hypoglycemic agent using neural networks.
    Haidar SH; Johnson SB; Fossler MJ; Hussain AS
    Pharm Res; 2002 Jan; 19(1):87-91. PubMed ID: 11837705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic population analysis in chronic renal failure using artificial neural networks--a comparative study.
    Gaweda AE; Jacobs AA; Brier ME; Zurada JM
    Neural Netw; 2003; 16(5-6):841-5. PubMed ID: 12850042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial neural networks for bilateral prediction of formulation parameters and drug release profiles from cochlear implant coatings fabricated as porous monolithic devices based on silicone rubber.
    Nemati P; Imani M; Farahmandghavi F; Mirzadeh H; Marzban-Rad E; Nasrabadi AM
    J Pharm Pharmacol; 2014 May; 66(5):624-38. PubMed ID: 24341981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of artificial neural networks to stratify the length of stay of cardiac patients based on preoperative and initial postoperative factors.
    Rowan M; Ryan T; Hegarty F; O'Hare N
    Artif Intell Med; 2007 Jul; 40(3):211-21. PubMed ID: 17580112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of artificial neural networks in medical science.
    Patel JL; Goyal RK
    Curr Clin Pharmacol; 2007 Sep; 2(3):217-26. PubMed ID: 18690868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. String matching artificial neural networks.
    Tambouratzis T
    Int J Neural Syst; 2001 Oct; 11(5):445-53. PubMed ID: 11709811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.
    Danhof M; de Lange EC; Della Pasqua OE; Ploeger BA; Voskuyl RA
    Trends Pharmacol Sci; 2008 Apr; 29(4):186-91. PubMed ID: 18353445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial neural networks as auxiliary tools for the improvement of bean plant architecture.
    Carneiro VQ; Silva GN; Cruz CD; Carneiro PCS; Nascimento M; Carneiro JES
    Genet Mol Res; 2017 Jun; 16(2):. PubMed ID: 28671250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effects.
    Mandema JW; Verotta D; Sheiner LB
    J Pharmacokinet Biopharm; 1992 Oct; 20(5):511-28. PubMed ID: 1287200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial neural networks: fundamentals, computing, design, and application.
    Basheer IA; Hajmeer M
    J Microbiol Methods; 2000 Dec; 43(1):3-31. PubMed ID: 11084225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.